Literature DB >> 4879792

Treatment of deep-vein thrombosis--a random trial.

V V Kakkar, C Flanc, M O'Shea, P Flute, C T Howe, M B Clarke.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4879792

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


× No keyword cloud information.
  9 in total

Review 1.  Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism.

Authors:  D K Cundiff; J Manyemba; J C Pezzullo
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

Review 2.  A systematic review of Cochrane anticoagulation reviews.

Authors:  David Keith Cundiff
Journal:  Medscape J Med       Date:  2009-01-06

3.  The problems of thrombosis in the deep veins of the leg.

Authors:  V V Kakkar
Journal:  Ann R Coll Surg Engl       Date:  1969-11       Impact factor: 1.891

Review 4.  Thrombolysis for acute deep vein thrombosis.

Authors:  Lorna Watson; Cathryn Broderick; Matthew P Armon
Journal:  Cochrane Database Syst Rev       Date:  2016-11-10

Review 5.  Anticoagulation therapy for venous thromboembolism.

Authors:  David K Cundiff
Journal:  MedGenMed       Date:  2004-09-09

6.  Clinical evidence for rebound hypercoagulability after discontinuing oral anticoagulants for venous thromboembolism.

Authors:  David Keith Cundiff
Journal:  Medscape J Med       Date:  2008-11-11

7.  Treatment of deep vein thrombosis. A trial of heparin, streptokinase, and arvin.

Authors:  V V Kakkar; C Flanc; C T Howe; M O'Shea; P T Flute
Journal:  Br Med J       Date:  1969-03-29

8.  Thrombolytic strategies versus standard anticoagulation for acute deep vein thrombosis of the lower limb.

Authors:  Cathryn Broderick; Lorna Watson; Matthew P Armon
Journal:  Cochrane Database Syst Rev       Date:  2021-01-19

Review 9.  Diet as prophylaxis and treatment for venous thromboembolism?

Authors:  David K Cundiff; Paul S Agutter; P Colm Malone; John C Pezzullo
Journal:  Theor Biol Med Model       Date:  2010-08-11       Impact factor: 2.432

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.